Q32 Bio Inc (QTTB) — Cash Flow-to-Debt Ratio
Q32 Bio Inc (QTTB) has a Cash Flow-to-Debt Ratio of -0.37x as of March 2026, meaning its operating cash flow of $-6.34 Million could theoretically repay 0% of its total liabilities ($17.36 Million) in one year. See Q32 Bio Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Q32 Bio Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Q32 Bio Inc across 10 annual periods. Also explore QTTB net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Q32 Bio Inc (2016–2025)
Year-by-year debt coverage analysis for Q32 Bio Inc. For market capitalisation and broader financial context, see QTTB market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.70x | $-33.54 Million | $19.76 Million | ▼ -117.2% |
| 2024 | -0.78x | $-67.72 Million | $86.66 Million | ▼ -862.2% |
| 2023 | -0.08x | $-18.68 Million | $229.98 Million | ▼ -42.7% |
| 2022 | -0.06x | $-10.96 Million | $192.49 Million | ▲ +97.8% |
| 2021 | -2.61x | $-109.75 Million | $42.07 Million | ▼ -87.3% |
| 2020 | -1.39x | $-94.33 Million | $67.74 Million | ▲ +20.6% |
| 2019 | -1.75x | $-91.36 Million | $52.06 Million | ▼ -158.7% |
| 2018 | -0.68x | $-42.56 Million | $62.74 Million | ▼ -510.7% |
| 2017 | 0.17x | $6.48 Million | $39.22 Million | ▲ +113.1% |
| 2016 | -1.26x | $-8.48 Million | $6.72 Million | — |